2025-04-08 19:13:16
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Godavari Drugs posts net profit of Rs. 1.26 crore in Q4 FY2022
Posted On : 2022-04-19 14:42:46( TIMEZONE : IST )
GODAVARI DRUGS LTD. has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 44.3961 crores during the period ended March 31, 2022 as compared to Rs. 33.8104 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 1.2675 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 1.3322 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 1.68 for the period ended March 31, 2022 as compared to Rs. 1.77 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 44.3961 crs | ₹33.8104 crs |  31.31% |
| Net Profit | ₹1.2675 crs | ₹1.3322 crs |  -4.86% |
| EPS | ₹1.68 | ₹1.77 | -5.08% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 44.3961 crores during the period ended March 31, 2022 as compared to Rs.33.0724 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.1.2675 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.1.2864 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.1.68 for the period ended March 31, 2022 as compared to Rs.1.71 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 44.3961 crs | ₹33.0724 crs | 34.24% |
| Net Profit | ₹1.2675 crs | ₹1.2864 crs | -1.47% |
| EPS | ₹1.68 | ₹1.71 | -1.75% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.161.3825 crores during the Financial Year ended March 31, 2022 as compared to Rs.123.0802 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.5.2453 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.4.1280 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.6.97 for the Financial Year ended March 31, 2022 as compared to Rs.5.48 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹161.3825 crs | ₹123.0802 crs | 31.12% |
| Net Profit | ₹5.2453 crs | ₹4.1280 crs | 27.07% |
| EPS | ₹6.97 | ₹5.48 | 27.19% |
Shares of GODAVARI DRUGS LTD. was last trading in BSE at Rs. 71.75 as compared to the previous close of Rs. 70.60. The total number of shares traded during the day was 10370 in over 141 trades.
The stock hit an intraday high of Rs. 73.90 and intraday low of 70.40. The net turnover during the day was Rs. 742522.00.
